{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:49Z","timestamp":1759334689299,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.arcmed.2005.04.015","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T07:42:00Z","timestamp":1133250120000},"page":"74-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thyroid Hormone and Insulin-Like Growth Factor-I in Patients with Multiple Myeloma Treated with Melphalan and Prednisone"],"prefix":"10.1016","volume":"37","author":[{"given":"Antoni","family":"Hrycek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Gruszka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2005.04.015_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0167-5699(94)90205-4","article-title":"The syntax of immune-neuroendocrine communication","volume":"15","author":"Blalock","year":"1994","journal-title":"Immunol Today"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2005.04.015_bib2","first-page":"37","article-title":"Hypothalamic-pituitary-thyroid axis and the immune system","volume":"46","author":"Komorowski","year":"1995","journal-title":"Endokryn Pol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199310213291708","article-title":"Neuroendocrine-immune interactions","volume":"329","author":"Reichlin","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2005.04.015_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000049012","article-title":"Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients","volume":"9","author":"Gad\u00f3","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.arcmed.2005.04.015_bib5","first-page":"226","article-title":"Prolactin in immunological processes","volume":"51","author":"Hrycek","year":"1998","journal-title":"Wiad Lek"},{"key":"10.1016\/j.arcmed.2005.04.015_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0065-2776(08)60860-3","article-title":"Prolactin, growth hormone, and insulin-like factor-I in the immune system","volume":"63","author":"Kooijman","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1191\/096120301678646173","article-title":"Selected serum cytokines in systemic lupus erythematosus treated with quinagolide","volume":"10","author":"Hrycek","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.arcmed.2005.04.015_bib8","first-page":"2140","article-title":"Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment","volume":"30","author":"Vera-Latra","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2005.04.015_bib10","article-title":"Concise Review of the Disease and Treatment Options. Multiple Myeloma. Cancer of the Bone Marrow. International Myeloma Foundation USA","author":"Durie","year":"2005","journal-title":"Edition"},{"year":"1966","series-title":"Elements of Mathematical Statistics and Investigational Methodology","author":"Oktaba","key":"10.1016\/j.arcmed.2005.04.015_bib11"},{"key":"10.1016\/j.arcmed.2005.04.015_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1018876","article-title":"The immunology of prolactin","volume":"10","author":"Berczi","year":"1992","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1999.tb07629.x","article-title":"Prolactin and neuroimmunomodulation: in vitro and in vivo observations","volume":"876","author":"Chikanza","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2005.04.015_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000049031","article-title":"Elevated levels of serum prolactin in patients with advanced multiple myeloma","volume":"9","author":"Gad\u00f3","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.arcmed.2005.04.015_bib15","first-page":"7","article-title":"The role of insulin-like growth factor-I in neuroendocrine function and the consequent effects on sexual maturation: interferences from animal models","volume":"3","author":"Chandrashekar","year":"2003","journal-title":"Reprod Biol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib16","first-page":"34","article-title":"Insulin-like growth factor-I (IGF-I) and neoplasms","volume":"12","author":"Kajdaniuk","year":"1999","journal-title":"Post N Med"},{"key":"10.1016\/j.arcmed.2005.04.015_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2003-10-3507","article-title":"Myeloma is on the move","volume":"103","author":"Shaughnessy","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2005.04.015_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2003-06-2066","article-title":"Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells","volume":"103","author":"Qiang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2005.04.015_bib19","first-page":"626","article-title":"Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway","volume":"111","author":"Ferlin","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib20","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V96.8.2856","article-title":"Insulin-like growth factor I is a dual effector of multiple myeloma cell growth","volume":"96","author":"Ge","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2005.04.015_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4049\/jimmunol.159.1.487","article-title":"A role for insulin-like growth factor in the regulation of IL-6 responsive human myeloma cell line growth","volume":"159","author":"Jelinek","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib22","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2002-05-1406","article-title":"Serum insulin growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2005.04.015_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1067\/msy.2000.105869","article-title":"Insulin and glucocorticoid-dependent supression of the IGF-I system in diabetic wounds","volume":"127","author":"Bitar","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2005.04.015_bib24","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/endo.136.11.7588206","article-title":"Transcriptional repression of insuline-like growth factor I by glucocorticoids in rat bone cells","volume":"136","author":"Delany","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2005.04.015_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1210\/endo.140.1.6411","article-title":"Cortisol enhances the expression of mac 25\/insulin like growth factor-binding protein-related protein-1 in cultured osteoblasts","volume":"140","author":"Pereira","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2005.04.015_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0093-691X(99)80009-0","article-title":"Glucocorticoid influence on porcine granulosa cell IGF-I and steroid hormone production in vitro","volume":"51","author":"Viveiros","year":"1999","journal-title":"Theriogenology"},{"key":"10.1016\/j.arcmed.2005.04.015_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002130000491","article-title":"Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone","volume":"152","author":"Watson","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.arcmed.2005.04.015_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1677\/joe.0.1360525","article-title":"The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers","volume":"136","author":"Miell","year":"1993","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03345472","article-title":"IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man","volume":"22","author":"Borges","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2005.04.015_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF03349028","article-title":"The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1","volume":"19","author":"Prummel","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2005.04.015_bib31","first-page":"79","article-title":"Functional characterisation of peripheral blood neutrophils in patients with hyperthyroidism","volume":"41","author":"Hrycek","year":"1995","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.arcmed.2005.04.015_bib32","first-page":"304","article-title":"Functional characterisation of peripheral blood neutrophils in patients with hypothyroidism","volume":"39","author":"Hrycek","year":"1993","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.arcmed.2005.04.015_bib33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0026-0495(97)90242-0","article-title":"Modulation of chronic excessive interleukin-6 production in multiple myeloma does not affect thyroid hormone concentrations","volume":"46","author":"van Zaanen","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.arcmed.2005.04.015_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.1993.tb02401.x","article-title":"The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism","volume":"39","author":"Docter","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib35","first-page":"111","article-title":"Thyroid function in elderly with neoplasms","volume":"90","author":"Tellini","year":"1999","journal-title":"Minerva Med"},{"key":"10.1016\/j.arcmed.2005.04.015_bib36","first-page":"161","article-title":"Vasselli C.The euthyroid sick syndrome. Its incidence and clinical significance in an internal medicine department","volume":"85","author":"Di Napoli","year":"1994","journal-title":"Minerva Med"},{"key":"10.1016\/j.arcmed.2005.04.015_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/thy.1997.7.125","article-title":"Euthyroid sick syndrome: an overview","volume":"7","author":"McIver","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2005.04.015_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/eje.0.1430179","article-title":"Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction","volume":"143","author":"Kimura","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib39","first-page":"719","article-title":"Euthyroid sick syndrome and inhibitory effect of sera on the activity of thyroid 5\u2032-deiodinase in systemic sclerosis","volume":"18","author":"Molnar","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arcmed.2005.04.015_bib40","first-page":"215","article-title":"Effect of chemotherapy on thyroid hormone concentration in patients with malignant hematologic diseases","volume":"28","author":"Nellen-Hummel","year":"1997","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2005.04.015_bib41","first-page":"77","article-title":"Neuroendocrine alterations in lung cancer patients","volume":"24","author":"Mazzoccoli","year":"2003","journal-title":"Neuroendocrinol Lett"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:31:17Z","timestamp":1759260677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440905002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0188440905002171"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.04.015","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid Hormone and Insulin-Like Growth Factor-I in Patients with Multiple Myeloma Treated with Melphalan and Prednisone","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}